|
Within the next few weeks, the American Heart Association is expected to release a scientific statement that will endorse heart scans to help predict which patients are at risk of future heart attacks and decide how aggressively to treat those in danger. The guidelines are expected to apply specifically to patients at “intermediate” risk of a heart attack based on their cholesterol levels, blood pressure, age and health habits. Up to 30% of patients who present with Major Acute Coronary Events (MACE) are classified as intermediate risk based on cholesterol, etc. |
It is important to note, however, that a separate study has shown that calcium was NOT detected in 19% of patients who suffered MACE (Am J Cardio. 1998: 81:272-275). In a recent prospective study, researchers enrolled over a 1000 asymptomatic, non-diabetic adults (mean age 69; 85% white) with at least one risk factor for heart attack and followed them for 76 months. At baseline, a Framingham risk score was calculated (we have these in the office in tabulated form; if we haven’t done one with you, you probably don’t have the major risk factor of high LDL cholesterol.) Click on this link to calculate your Framingham risk. Calcium scores were determined for each subject in the trial. Among those with a 10% or greater 10 year predicted risk, calcium scores significantly contributed to the prediction of MACE. For example, within an intermediate-risk group (Framingham scores of 10%-15%), the proportion of patients with cardiac events ranged from 2.5% among patients with calcium scores of zero (2 events in 79 patients) to 19.5% among patients with calcium scores higher than 300 (8 events in 41 patients.)(JAMA 2004 Jan 14;291:210-5.) There remain controversies and dilemmas associated with use of heart scans. For example, by age 80, virtually everyone has calcium deposits in their coronary arteries. Should we treat everyone over age 80? Do frequent heart scans improve patients outcomes? It is clear that heart scan-based calcium scores contribute very little predictive information for patients with very low or very high Framingham scores. It is expected that upon the release of the American Heart Association Scientific Statement, insurance coverage will improve for heart scans. However, it is important to keep in mind that there is no perfect test to predict who is in immanent danger of MACE. High risk patients should not use this test as an excuse to ignore and leave untreated important risk factors such as high LDL, high blood pressure, obesity or smoking. Another concern involves radiation exposure. There are two heart scan technologies out there: electron beam and ultrafast CT. Electron beam delivers less radiation. For women, the major radiosensitive organ in the field of a heart scan is breast. We really don’t know if low dose radiation causes breast cancer or not. All we can do is extrapolate down from atomic bomb data. No matter how you look at it, having a heart scan is low risk (especially electron beam). The procedure with the most radiation, a Siemens scan, is equivalent to approximately six mammograms. If heart scans are done infrequently, this dose poses a very low risk. Although we are recommending heart scans in the setting of intermediate risk patients, anyone can have one done. We are referring to Front Range Preventative Imaging. Call your insurance to see if the test is covered, and under what circumstances. |
added: 26 September 2004 |